1家供應(yīng)商在售
|
||||||
商品名稱 | 規(guī)格 | 代理級別 | 價格 | 運費 | 供應(yīng)商 | 購買 |
CD20 (L26) Mouse mAb
交貨周期:現(xiàn)貨
|
100 μl | 經(jīng)銷 |
登錄可見
|
- |
北京敏泰元科技有限公司 |
庫存:20
|
REACTIVITY | H |
SENSITIVITY | Endogenous |
MW (kDa) | |
Source/Isotype | Mouse IgG2a kappa |
Application | Dilution |
---|---|
IHC-Leica? Bond? | 1:4000 - 1:16000 |
Immunohistochemistry (Paraffin) | 1:2000 - 1:8000 |
Supplied in 10 mM PBS containing 0.05% BSA and 0.05% sodium azide. Stable for 24 months when stored at -20°C. This product will freeze at -20°C so it is recommended to aliquot into single-use vials to avoid multiple freeze/thaw cycles. A slight precipitate may be present, but will not interfere with antibody performance.
CD20 (L26) Mouse mAb recognizes endogenous levels of total CD20 protein.
Human
Monoclonal antibody is produced by immunizing animals with human tonsil B cells.
B-lymphocyte antigen CD20 (also known as MS4A1; Membrane-spanning 4-domains subfamily A member 1) is a cell surface phosphoprotein involved in the regulation of B cell activation and proliferation (1,2). It is commonly used as a marker to identify B cells and is expressed throughout B cell development, up until their differentiation into plasma cells. CD20 has no known ligand, and its expression and function are largely conserved between human and mouse (1-3). Evidence suggests that CD20 is necessary for store operated calcium (SOC) entry, which leads to elevated cytoplasmic calcium levels required for B cell activation (4-5). Anti-CD20 antibody immunotherapy depletes B cells by activation of the innate monocytic network and is a common treatment for B cell lymphomas, leukemias, and autoimmune diseases (6).
商城介紹 | 媒體報道 | 法規(guī)政策 | 協(xié)議專區(qū)
京公網(wǎng)安備 11010802025067號 增值電信業(yè)務(wù)經(jīng)營許可證:京B2-20171454 ICP備案號:京ICP備16050672號-1
喀斯瑪科技版權(quán)所有 2017-
藥品醫(yī)療器械網(wǎng)絡(luò)信息服務(wù)備案: (京)-網(wǎng)藥械信息備字(2022)第00393號
醫(yī)療器械網(wǎng)絡(luò)交易服務(wù)第三方平臺備案編號:京網(wǎng)械平臺備字(2021)第00006號
網(wǎng)絡(luò)食品交易第三方平臺提供者備案 :京食藥網(wǎng)食備202110062 信息系統(tǒng)安全等級保護備案證明(三級)